Showing results (1-10 of 369) with videos related to
Sort By:
Pageof 37
Journal of Gastroenterology|October 2, 2014
MICA SNPs and the NKG2D system in virus-induced HCCKaku Goto, Naoya KatoNihon Rinsho. Japanese Journal of Clinical Medicine|May 10, 2012
[New antivirals against hepatitis C virus]Naoya Kato, Ryosuke Muroyama, Kaku GotoNihon Rinsho. Japanese Journal of Clinical Medicine|March 14, 2015
[Hepatitis C virus induced hepatocellular carcinoma associated genes]Naoya Kato, Ryosuke Muroyama, Kaku GotoOncotarget|September 8, 2016
Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitroKaku Goto, Naoya Kato, Raymond T ChungOncotarget|May 4, 2018
Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10Kaku Goto, Jun Arai, Anthony Stephanou, et al.Plos One|May 6, 2015
The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global dataWenwen Li, Kaku Goto, Yasuo Matsubara, et al.Virology|August 6, 2014
The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levelsChikako Shibata, Motoko Ohno, Motoyuki Otsuka, et al.Scientific Reports|December 3, 2016
Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association studyKaku Goto, Dorcas A Annan, Tomoko Morita, et al.International Journal of Cancer|June 7, 2018
Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cellsJun Arai, Kaku Goto, Yasushi Tanoue, et al.Journal of Gastroenterology|May 22, 2013
IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infectionMasaya Sato, Naoya Kato, Ryosuke Tateishi, et al.Pageof 37